Dopamine: Chemistry and Function

Dopamine has become a buzzword: “dopamine hits” from social media, “dopamine fasting”, “dopamine dressing”. The real molecule is more interesting than the slogans. It’s a small catecholamine that helps you move smoothly, makes you want things, and teaches your brain which actions pay off. Losing it causes Parkinson’s disease; drugs that flood the brain with it cause addiction. Here’s what the chemistry and the science actually say.

Identity

Property	Value
Chemical name	4-(2-aminoethyl)benzene-1,2-diol
Formula	C₈H₁₁NO₂
Molar mass	153.18 g mol⁻¹
Class	Catecholamine (monoamine neurotransmitter)
Made from	Tyrosine, via L-DOPA

Structure

Dopamine has:

• a catechol group: a benzene ring with two –OH groups on neighbouring carbons;
• a two-carbon ethylamine side chain ending in a primary amine (–NH₂).

At body pH, the amine is protonated (–NH₃⁺), making dopamine charged and water-soluble. Unlike adrenaline, dopamine has no chiral centre.

Dopamine is the parent of the catecholamine family: add an –OH to its side chain and you get noradrenaline; add a methyl group to noradrenaline’s nitrogen and you get adrenaline (see adrenaline).

Making and breaking dopamine

Synthesis

In dopamine-producing nerve cells:

1. Tyrosine → L-DOPA: the enzyme tyrosine hydroxylase adds an –OH group to the ring. This is the slowest step and is tightly regulated.
2. L-DOPA → dopamine: the enzyme aromatic L-amino acid decarboxylase removes the carboxyl group as CO₂. This enzyme uses a coenzyme made from vitamin B6 (see cofactors and coenzymes).

Dopamine is then packed into vesicles, ready for release.

Switching off

After release, dopamine’s action is ended by:

• reuptake through the dopamine transporter (DAT) back into the nerve cell;
• breakdown by two enzymes: monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT). The main final product is homovanillic acid, excreted in urine.

The catechol ring is easily oxidised, which is one reason dopamine-producing neurons are thought to be vulnerable to oxidative stress (see oxidation and reduction).

Where dopamine works

Although dopamine neurons make up only a tiny fraction of the brain’s cells, they project widely. The main pathways:

• Nigrostriatal pathway: from the substantia nigra to the striatum. Controls movement. The substantia nigra (“black substance”) looks dark because dopamine-making neurons contain neuromelanin, a pigment formed from oxidised dopamine.
• Mesolimbic pathway: from the ventral tegmental area to the nucleus accumbens. Involved in motivation and reward.
• Mesocortical pathway: to the prefrontal cortex. Involved in attention, planning and working memory.
• Tuberoinfundibular pathway: to the pituitary gland, where dopamine inhibits the release of prolactin, a hormone.

Dopamine acts on five receptor types (D1 to D5), all linked to G proteins, so its effects tend to modulate other signals rather than switch neurons fully on or off.

What dopamine really does: reward prediction, not pleasure

Popular articles often call dopamine the “pleasure chemical”. Research tells a more precise story.

In the 1990s, Wolfram Schultz recorded dopamine neurons in monkeys:

• When an unexpected reward (a squirt of juice) arrived, dopamine neurons fired a burst.
• After the monkey learned that a light predicted the juice, the neurons fired at the light, not the juice.
• If the light came but the juice didn’t, dopamine activity dipped below normal at the moment the juice should have arrived.

So dopamine seems to signal reward prediction error: the difference between what was expected and what happened. This teaches the brain which cues and actions lead to good outcomes. Dopamine is more about wanting and learning than about the feeling of pleasure itself, which depends on other systems, including opioids (see endorphins).

Parkinson’s disease and L-DOPA

In Parkinson’s disease, dopamine-producing neurons in the substantia nigra gradually die. By the time symptoms appear (tremor, stiffness, slow movement, difficulty starting movements), a large proportion of these neurons have been lost.

The obvious treatment, giving dopamine, doesn’t work: charged dopamine can’t cross the blood–brain barrier. But its precursor L-DOPA can, because it’s an amino acid and is carried across by amino acid transporters. Once in the brain, surviving neurons convert it to dopamine.

This treatment grew out of work by the Swedish pharmacologist Arvid Carlsson in the late 1950s, who showed that dopamine was a neurotransmitter in its own right (not just an intermediate on the way to noradrenaline) and that L-DOPA could reverse movement problems in animals depleted of dopamine. He shared the 2000 Nobel Prize in Physiology or Medicine.

In practice, L-DOPA is given with a drug (such as carbidopa) that blocks its conversion to dopamine outside the brain, reducing side effects like nausea and allowing more to reach the brain. Over years, its effectiveness can fluctuate, and other drugs that mimic dopamine or slow its breakdown are also used.

Drugs that affect dopamine

Drug	Action on the dopamine system	Result
Cocaine	Blocks the dopamine transporter (DAT)	Dopamine stays in the synapse longer
Amphetamine, methamphetamine	Reverse the transporter, pushing dopamine out	Large dopamine release
Antipsychotics	Block D2 receptors	Reduce symptoms of psychosis; can cause movement side effects
L-DOPA	Precursor, converted to dopamine	Treats Parkinson’s disease
Methylphenidate	Blocks DAT (and noradrenaline transporter)	Used to treat ADHD
MAO-B inhibitors	Slow dopamine breakdown	Used in Parkinson’s disease

Addictive drugs share a tendency to increase dopamine signalling in the mesolimbic pathway far more powerfully than natural rewards, which helps explain how they hijack learning and motivation.

Dopamine outside the brain

Dopamine also acts in the body: it’s used as an intravenous drug to support blood pressure and heart function in intensive care, and it’s involved in kidney function. Given this way, it doesn’t reach the brain.

Common misconceptions

• “Dopamine is the pleasure molecule.” It’s more closely linked to motivation, anticipation and learning from surprises.
• “You can ‘detox’ from dopamine.” The brain can’t stop making dopamine; “dopamine fasting” is really about changing habits and cues.
• “Eating dopamine-rich foods boosts brain dopamine.” Dietary dopamine can’t cross the blood–brain barrier.

Measuring dopamine

Neuroscientists measure dopamine in several ways. Fast-scan cyclic voltammetry uses a tiny carbon-fibre electrode placed in the brain of an experimental animal; because dopamine’s catechol group is easily oxidised, a rapidly changing voltage oxidises and reduces it at the electrode surface, producing a current that reveals changes in dopamine concentration within fractions of a second (see oxidation and reduction). Microdialysis collects fluid from the brain for analysis by chromatography. In humans, PET scanning with radioactive tracers that bind dopamine receptors or transporters can estimate dopamine release and the health of dopamine neurons, which helps diagnose Parkinson’s disease.

Key takeaways

• Dopamine (C₈H₁₁NO₂) is a catecholamine made from tyrosine via L-DOPA; it’s the parent of noradrenaline and adrenaline.
• It’s cleared by reuptake (DAT) and broken down by MAO and COMT.
• It controls movement (nigrostriatal pathway) and motivation and learning (mesolimbic pathway), signalling reward prediction error rather than pleasure itself.
• Parkinson’s disease results from loss of dopamine neurons; L-DOPA crosses the blood–brain barrier and restores dopamine.
• Cocaine, amphetamines and antipsychotics act on the dopamine system. For the wider family, see neurotransmitters.